More than 500 million people worldwide are persistently infected with the hepatitis B virus
(HBV) and/or hepatitis C virus (HCV) and are at risk of developing chronic liver disease …

The hepatitis C virus (HCV) persists in the majority of infected individuals and is a significant
cause of human illness and death globally. Recent studies have yielded important insights …

Psoriasis is a common T-cell-mediated skin disease with 2–3% prevalence worldwide.
Psoriasis is considered to be an autoimmune disease, but the precise nature of the …

The T-cell biology of the liver is unlike that of any other organ. The local lymphocyte
population is enriched in natural killer (NK) and NKT cells, which might have crucial roles in …

Hepatitis C virus (HCV) causes acute and chronic hepatitis which can eventually lead to
permanent liver damage, hepatocellular carcinoma and death. Currently, there is no vaccine …

The innate immune system has a role not only in protecting the host during the initial period
of virus infection, but also in shaping the nature of the adaptive immune response. In this …

▪ Abstract The hepatitis C virus (HCV) infects approximately three percent of the world's
population. Some individuals resolve the infection spontaneously, but the majority develop …

Persistent infection with hepatitis C virus (HCV) is among the leading causes of chronic liver
disease. Previous studies suggested that genetic variation in hypervariable region 1 (HVR1) …

Hepatitis C virus (HCV) is a hepatotropic RNA virus that causes acute and chronic hepatitis,
liver cirrhosis, and hepatocellular carcinoma. It is widely accepted that cellular immune …

Patients infected with hepatitis C virus (HCV) have an impaired response against HCV
antigens while keeping immune competence for other antigens. We hypothesized that …